NCT05922605View on ClinicalTrials.gov

Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

PHASE4RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

May 1, 2025

Conditions
Postoperative AnalgesiaS-ketaminePediatricsCaudal BlockHypospadias
Interventions
DRUG

S-ketamine & Ropivacaine

The experiment group (Group E) will receive a mixture of ropivacaine 0.2% 0.7 ml／kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.

DRUG

Ropivacaine

The experiment group (Group C) will receive ropivacaine 0.2% 0.7 ml／kg plain and equial volume saline caudally for postoperative analgesia.

Trial Locations (1)

510000

RECRUITING

First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Tao Zhang

OTHER